Beta
254589

Antitumor efficacy of Curcumin nanoparticles

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Pharmaceutical Chemistry

Abstract

The present study tried to evaluate the anticancer ability of curcumin by decreasing its adverse effects and increasing its bioavailability. In this work curcumin was loaded in nano emulsions then characterized by transmission electron microscope (TEM). The antitumor efficacy of the curcumin nano emulsions was assessed in mice by DNA comet assay analysis, FTIR and examination of tumor histopathology. The obtained results found that mice treated with curcumin nano emulsions were effective in reducing DNA damage and changes in tumor tissue structure. In conclusion, curcumin nano emulsions have potential efficiency in treating tumor tissues.

DOI

10.21608/ejchem.2022.152966.6623

Keywords

Nano curcumin, Tumor, comet

Authors

First Name

Eman

Last Name

Abdelmoneam

MiddleName

-

Affiliation

Biophysics Department, Faculty of Science, Cairo University, Egypt.

Email

eman_abdelmoneam20@yahoo.com

City

-

Orcid

-

First Name

Monira

Last Name

Rageh

MiddleName

-

Affiliation

Biophysics Department, Faculty of Science, Cairo University, Egypt.

Email

mrageh@sci.cu.edu.eg

City

-

Orcid

-

First Name

Ebtesam

Last Name

Mohamad

MiddleName

A.

Affiliation

Biophysics Department, Faculty of Science, Cairo University, Egypt.

Email

imohamed@sci.cu.edu.eg

City

Giza

Orcid

0000-0001-5296-896X

Volume

66

Article Issue

4

Related Issue

40820

Issue Date

2023-04-01

Receive Date

2022-07-28

Publish Date

2023-04-01

Page Start

403

Page End

406

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_254589.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=254589

Order

254,589

Type

Original Article

Type Code

297

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Antitumor efficacy of Curcumin nanoparticles

Details

Type

Article

Created At

30 Dec 2024